Daniel Massó-Vallés

1.4k total citations
12 papers, 745 citations indexed

About

Daniel Massó-Vallés is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, Daniel Massó-Vallés has authored 12 papers receiving a total of 745 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 8 papers in Oncology and 4 papers in Genetics. Recurrent topics in Daniel Massó-Vallés's work include Protein Degradation and Inhibitors (4 papers), Pancreatic and Hepatic Oncology Research (3 papers) and Chronic Lymphocytic Leukemia Research (3 papers). Daniel Massó-Vallés is often cited by papers focused on Protein Degradation and Inhibitors (4 papers), Pancreatic and Hepatic Oncology Research (3 papers) and Chronic Lymphocytic Leukemia Research (3 papers). Daniel Massó-Vallés collaborates with scholars based in Spain, United Kingdom and United States. Daniel Massó-Vallés's co-authors include Laura Soucek, Jonathan R. Whitfield, Gérard I. Evan, Erika Serrano, Nicole M. Sodir, Marie-Ève Beaulieu, Lamorna Brown Swigart, Anthony N. Karnezis, Toni Jauset and Joaquı́n Arribas and has published in prestigious journals such as Nature Communications, Genes & Development and Cancer Research.

In The Last Decade

Daniel Massó-Vallés

12 papers receiving 736 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Daniel Massó-Vallés Spain 9 546 297 168 77 71 12 745
Dorine Bellanger France 11 330 0.6× 201 0.7× 199 1.2× 103 1.3× 60 0.8× 15 586
Dongyin Yu United States 7 498 0.9× 194 0.7× 151 0.9× 57 0.7× 48 0.7× 9 685
Rosa I. Gallagher United States 15 413 0.8× 345 1.2× 184 1.1× 83 1.1× 140 2.0× 27 808
Shengyan Xiang United States 16 765 1.4× 273 0.9× 109 0.6× 58 0.8× 48 0.7× 25 919
Arnaud Guillé France 15 458 0.8× 312 1.1× 353 2.1× 49 0.6× 76 1.1× 42 856
Thanh Von United States 10 628 1.2× 289 1.0× 110 0.7× 45 0.6× 85 1.2× 11 808
Andrew Capen United States 9 511 0.9× 212 0.7× 89 0.5× 42 0.5× 121 1.7× 19 724
Alba Gonzàlez-Juncà United States 8 527 1.0× 253 0.9× 141 0.8× 96 1.2× 74 1.0× 13 697
John P. Gustin United States 11 512 0.9× 206 0.7× 150 0.9× 27 0.4× 49 0.7× 12 641
Roza Zandi Denmark 7 324 0.6× 264 0.9× 103 0.6× 37 0.5× 47 0.7× 9 540

Countries citing papers authored by Daniel Massó-Vallés

Since Specialization
Citations

This map shows the geographic impact of Daniel Massó-Vallés's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Massó-Vallés with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Massó-Vallés more than expected).

Fields of papers citing papers by Daniel Massó-Vallés

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel Massó-Vallés. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Massó-Vallés. The network helps show where Daniel Massó-Vallés may publish in the future.

Co-authorship network of co-authors of Daniel Massó-Vallés

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel Massó-Vallés. A scholar is included among the top collaborators of Daniel Massó-Vallés based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel Massó-Vallés. Daniel Massó-Vallés is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Fluck, Mariano F. Zacarías, Daniel Massó-Vallés, Sílvia Casacuberta‐Serra, et al.. (2023). Reducing MYC's transcriptional footprint unveils a good prognostic gene signature in melanoma. Genes & Development. 37(7-8). 303–320. 5 indexed citations
2.
Beaulieu, Marie-Ève, et al.. (2023). Pharmacokinetic Analysis of Omomyc Shows Lasting Structural Integrity and Long Terminal Half-Life in Tumor Tissue. Cancers. 15(3). 826–826. 10 indexed citations
3.
Fluck, Mariano F. Zacarías, Toni Jauset, Sandra Martínez-Martín, et al.. (2021). The Wnt signaling receptor Fzd9 is essential for Myc-driven tumorigenesis in pancreatic islets. Life Science Alliance. 4(5). e201900490–e201900490. 7 indexed citations
4.
Massó-Vallés, Daniel, Marie-Ève Beaulieu, & Laura Soucek. (2020). MYC, MYCL, and MYCN as therapeutic targets in lung cancer. Expert Opinion on Therapeutic Targets. 24(2). 101–114. 82 indexed citations
5.
Massó-Vallés, Daniel & Laura Soucek. (2020). Blocking Myc to Treat Cancer: Reflecting on Two Decades of Omomyc. Cells. 9(4). 883–883. 112 indexed citations
6.
Jauset, Toni, Daniel Massó-Vallés, Sandra Martínez-Martín, et al.. (2018). BET inhibition is an effective approach against KRAS-driven PDAC and NSCLC. Oncotarget. 9(27). 18734–18746. 12 indexed citations
7.
Pedersen, Kim, Cristina Bernadó Morales, Teresa Macarulla, et al.. (2017). Pancreatic cancer heterogeneity and response to Mek inhibition. Oncogene. 36(40). 5639–5647. 18 indexed citations
8.
Massó-Vallés, Daniel, Toni Jauset, & Laura Soucek. (2016). Ibrutinib repurposing: from B-cell malignancies to solid tumors. Oncoscience. 3(5-6). 147–148. 17 indexed citations
9.
Massó-Vallés, Daniel, Toni Jauset, Erika Serrano, et al.. (2015). Ibrutinib Exerts Potent Antifibrotic and Antitumor Activities in Mouse Models of Pancreatic Adenocarcinoma. Cancer Research. 75(8). 1675–1681. 92 indexed citations
10.
Annibali, Daniela, Jonathan R. Whitfield, Emilia Favuzzi, et al.. (2014). Myc inhibition is effective against glioma and reveals a role for Myc in proficient mitosis. Nature Communications. 5(1). 4632–4632. 145 indexed citations
11.
Soucek, Laura, Jonathan R. Whitfield, Nicole M. Sodir, et al.. (2013). Inhibition of Myc family proteins eradicates KRas-driven lung cancer in mice. Genes & Development. 27(5). 504–513. 244 indexed citations
12.
Soucek, Laura, Daniel Massó-Vallés, Toni Jauset, et al.. (2012). 916 Modeling Pharmacological Inhibition of Bruton's Tyrosine Kinase (BTK) as a Therapy for Insulinoma and Pancreatic Ductal Adenocarcinoma. European Journal of Cancer. 48. S222–S222. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Dorine Bellanger Breakdown of academic impact, for papers by Dongyin Yu Breakdown of academic impact, for papers by Rosa I. Gallagher Breakdown of academic impact, for papers by Shengyan Xiang Breakdown of academic impact, for papers by Arnaud Guillé Breakdown of academic impact, for papers by Thanh Von Breakdown of academic impact, for papers by Andrew Capen Breakdown of academic impact, for papers by Alba Gonzàlez-Juncà Breakdown of academic impact, for papers by John P. Gustin Breakdown of academic impact, for papers by Roza Zandi
Rankless by CCL
2026